Differential Susceptibilities to Azithromycin Treatment of Chlamydial Infection in the Gastrointestinal Tract and Cervix
Authors:
Open Access
- 1 December 2013
- journal article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 57 (12) , 6290-6294
Abstract
Evidence from animal studies suggests that chlamydiae may persist in the gastrointestinal tract (GI) and be a reservoir for reinfection of the genital tract. We hypothesize that there may be a differential susceptibility of organisms in the GI and genital tracts. To determine the effect of azithromycin on persistent chlamydial gut infection, C57BL/6 and BALB/c mice were infected orally and genitally and treated with azithromycin (Az) orally (20, 40, or 80 mg/kg of body weight), and the numbers of chlamydiae were determined from cervix and cecal tissues. The Az concentration in the cecum and cervix was measured by high-performance liquid chromatography with electrochemical detection (HPLC-ECD). Az treatment cleared genital infection in both C57BL/6 and BALB/c mice; however, GI infection was not cleared with the same doses. HPLC data showed the presence of Az at both sites of infection, and significant amounts of Az were measured in treatment groups. However, no significant difference in Az levels between the cecum and the cervix was observed, indicating similar levels of Az reaching both sites of infection. These data indicate that antibiotic levels that are sufficient to cure genital infection are ineffectual against GI infection. The results suggest a reevaluation of antibiotic therapy for chlamydial infection.Keywords
This publication has 21 references indexed in Scilit:
- Azithromycin antimicrobial resistance and genitalChlamydia trachomatisinfection: duration of therapy may be the key to improving efficacySexually Transmitted Infections, 2012
- Re-Evaluating the Treatment of Nongonococcal Urethritis: Emphasizing Emerging Pathogens-A Randomized Clinical TrialClinical Infectious Diseases, 2010
- RepeatedChlamydia trachomatisGenital Infections in Adolescent WomenThe Journal of Infectious Diseases, 2010
- The case for further treatment studies of uncomplicated genital Chlamydia trachomatis infectionSexually Transmitted Infections, 2006
- Evaluation of Antimicrobial Resistance and Treatment Failures forChlamydiatrachomatis: A Meeting ReportThe Journal of Infectious Diseases, 2005
- Effect of Expedited Treatment of Sex Partners on Recurrent or Persistent Gonorrhea or Chlamydial InfectionNew England Journal of Medicine, 2005
- Azithromycin Versus Doxycycline for Genital Chlamydial InfectionsSexually Transmitted Diseases, 2002
- Inflammation and Clearance ofChlamydia trachomatisin Enteric and Nonenteric MucosaeInfection and Immunity, 2001
- Chlamydial cervicitis and urethritis: single dose treatment compared with doxycycline for seven days in community based practises.Sexually Transmitted Infections, 1996
- A Controlled Trial of a Single Dose of Azithromycin for the Treatment of Chlamydial Urethritis and CervicitisNew England Journal of Medicine, 1992